USPTO 2015–2025 USPTO PatentsView US Corporation

The Nemours Foundation

USPTO PatentsView assignee record - 11 granted patents across 18 technology areas, active 2016–2025. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: C07K (PEPTIDES).

Compiled byPlainPatent Editorial, US Patent Intelligence Editorial Team

Explore the portfolio See the ranking

Total patents granted

CPC technology areas

25.2

Avg claims per patent

+20%

5-year filing velocity

The verdict

The holds 11 US patents across 18 technology areas, rank #25,395 of 50,000 tracked assignees.

#25,395
of 50,000 US assignees by volume: Top 4%
by Innovation Score (58.6/100): 25.2
avg claims per patent: +20%
filing velocity, last 5 yrs

Portfolio overview

The Nemours Foundation has been granted 11 US utility patents between 2016 and 2025, placing The Nemours Foundation at rank #25,395 across all assignees tracked by PlainPatent. This portfolio spans 18 distinct Cooperative Patent Classification (CPC) subclasses, averaging 25.2 claims per patent with primary concentration in C07K (PEPTIDES). As a US Corporation, The Nemours Foundation is one of the more focused assignees in the PatentsView dataset. By volume, The sits between The Carlstar Group Llc (11 patents, rank #25,391) and Theracell, Llc (11 patents, rank #25,399) - the closest US assignees by grant volume. The composite Innovation Score of 58.6/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.

Filing cadence tells the strategic story. Between 2020 and 2025 the company received 6 grants, compared with 5 in the 2015–2019 window, a +20% shift in five-year velocity. Steady filing volume suggests sustained innovation without dramatic pivots. The US Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.

Claim depth and technology breadth together indicate competitive posture. The Nemours Foundation's 25.2 average claims per patent reflects complex, broadly scoped inventions that are difficult for competitors to design around, while concentration in 18 subclasses points to a focused technical program. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark The Nemours Foundation against peers pursuing similar technology classes.

The Carlstar Group

11
The Container Sto…

11
The Crosby Group

11
The Island Radar

11
The Notebook

11
The Swatch Group…

11
The University of…

11
Theracell

11
The Nemours Found… ◀

11

What this shows The holds 11 patents at rank #25,395, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

The's Innovation Score vs. every tracked assignee

Composite of portfolio volume, filing velocity, technology breadth, and claim depth (0–100)

59 Top 4% higher than 96% of 50,000 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2016–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2016–2019 baseline. Full figures in the table below.

View data table

The Nemours Foundation patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2016	1	9.1%
2017	1	9.1%
2018	2	18.2%
2019	1	9.1%
2022	3	27.3%
2023	1	9.1%
2025	2	18.2%

Which technologies does The Nemours Foundation patent most?

C07K - PEPTIDES 4

A61K - PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES 4

C12N - MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA 4

A61P - SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS 3

A61H - PHYSICAL THERAPY APPARATUS, e.g. DEVICES FOR LOCATING OR STIMULATING REFLEX POINTS IN THE BODY; ARTIFICIAL RESPIRATION; MASSAGE; BATHING DEVICES FOR SPECIAL THERAPEUTIC OR HYGIENIC PURPOSES OR SPECIFIC PARTS OF THE BODY 2

A61B - DIAGNOSIS; SURGERY; IDENTIFICATION 2

Y02A - TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE 1

B29C - SHAPING OR JOINING OF PLASTICS; SHAPING OF MATERIAL IN A PLASTIC STATE, NOT OTHERWISE PROVIDED FOR; AFTER-TREATMENT OF THE SHAPED PRODUCTS, e.g. REPAIRING 1

G05B - CONTROL OR REGULATING SYSTEMS IN GENERAL; FUNCTIONAL ELEMENTS OF SUCH SYSTEMS; MONITORING OR TESTING ARRANGEMENTS FOR SUCH SYSTEMS OR ELEMENTS 1

B33Y - ADDITIVE MANUFACTURING, i.e. MANUFACTURING OF THREE-DIMENSIONAL [3-D] OBJECTS BY ADDITIVE DEPOSITION, ADDITIVE AGGLOMERATION OR ADDITIVE LAYERING, e.g. BY 3-D PRINTING, STEREOLITHOGRAPHY OR SELECTIVE LASER SINTERING 1

A61L - METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES 1

A61F - FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRS 1

G02F - OPTICAL DEVICES OR ARRANGEMENTS FOR THE CONTROL OF LIGHT BY MODIFICATION OF THE OPTICAL PROPERTIES OF THE MEDIA OF THE ELEMENTS INVOLVED THEREIN; NON-LINEAR OPTICS; FREQUENCY-CHANGING OF LIGHT; OPTICAL LOGIC ELEMENTS; OPTICAL ANALOGUE/DIGITAL CONVERTERS 1

C12Y - ENZYMES 1

A01K - ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS 1

Top 15 of 18 technology areas

Patent Moat Analysis

Portfolio Volume Light

Tech Breadth Focused

Claim Depth Complex

Velocity Growing

Where it ranks

Overall rank by patents

#25,395

Across all tracked assignees

Innovation Score

58.6 out of 100

View all rankings →

Data Source

USPTO PatentsView, US granted patents 2015–2025

How is Innovation Score calculated?

Frequently Asked Questions

How many patents does The Nemours Foundation hold?

The Nemours Foundation holds 11 US granted patents filed between 2016 and 2025, spanning 18 technology areas.

What is The Nemours Foundation's Innovation Score?

The Nemours Foundation has an Innovation Score of 58.6 out of 100. This composite metric weighs portfolio volume (40%), filing velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does The Nemours Foundation focus on?

The Nemours Foundation's top technology area is C07K (PEPTIDES) with 4 patents. The company has filed patents in 18 CPC subclasses total.

Is The Nemours Foundation's patent filing rate increasing or decreasing?

The Nemours Foundation's recent filing velocity is +20% compared to the prior five-year period. The company is maintaining or growing its patent output.

What does claim depth mean for The Nemours Foundation's patents?

The Nemours Foundation's patents average 25.2 claims each. This indicates complex, broadly scoped patents that are harder for competitors to design around.

How is the The Nemours Foundation patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

How to use this portfolio

The's 11 grants land it in the top 4% by Innovation Score, but volume alone doesn't tell you where the strength sits.

Read that count against the largest US assignees before treating it as dominance - The ranks #25,395 of 50,000. Top 50 holders
Most of this portfolio concentrates in C07K - see who else leads that technology area. C07K leaders
Check what the four-part Innovation Score actually rewards before comparing it to another company. How the score works

Patent counts and the Innovation Score measure patenting activity, not commercial success or the legal strength of any patent. Many patents are filed defensively. Verify the status of an individual patent against official USPTO records.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent Editorial

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled byPlainPatent Editorial, US Patent Intelligence Editorial Team

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.